Novo Nordisk A/S ADR (NVO)
NYSE · ADR · CUSIP K7314N152
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NVO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
K7314N152
Market Cap
Large Cap
ADR Ratio
2:1
Business: Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

Company Contact

CEO
Lars Rebien Sørensen
CFO
Karsten Munk Knudsen
Headquarters
100 College Road West, Princeton, NJ 08540
Phone
609-919-8567
Investor Relations
609-919-8567 · phak@novonordisk.com
SEC EDGAR Filings
View filings »